Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.French-headquartered Valneva is one of four companies developing a vaccine against Covid-19 that has signed a supply deal with the UK Government’s Vaccines Taskforce.
According to the terms of the deal, Valneva is set to supply 60 million doses of its inactivated whole Covid-19 vaccine candidate, VLA2001, from mid- 2021.
Valneva is hoping to initiate clinical trials of VLA2001 by the end of this year. The 60 million doses for the UK market will be produced at Valneva’s manufacturing facility in Livingstone, Scotland.